Skip Navigation



American Journal of Epidemiology Advance Access published online on March 5, 2007

American Journal of Epidemiology, doi:10.1093/aje/kwm018
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
165/10/1170    most recent
kwm018v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rosso, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosso, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Copyright © 2007 by the Johns Hopkins Bloomberg School of Public Health All rights reserved; printed in U.S.A.

ORIGINAL CONTRIBUTION

Is 2,3,5-Pyrroletricarboxylic Acid in Hair a Better Risk Indicator for Melanoma than Traditional Epidemiologic Measures for Skin Phenotype?

Stefano Rosso1, Roberto Zanetti1, Maria José Sánchez2, Adoración Nieto3, Ana Miranda4, Mariette Mercier5, Dora Loria6, Anne Østerlind7, Rüdiger Greinert8, Maria-Dolores Chirlaque9, Gabriella Fabbrocini10, Cesare Barbera11, Hélène Sancho-Garnier12, Carmela Lauria13, Daniela Balzi14, Marina Zoccola15 and for the Helios Working Group

1 Oncology Prevention Center, Piedmont Cancer Registry, Turin, Italy
2 Granada Cancer Registry, Andalusian School of Public Health, Granada, Spain
3 Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Seville, Seville, Spain
4 Regional Cancer Registry, Southern Portugal Regional Institute of Oncology, Lisbon, Portugal
5 Doubs Cancer Registry, Faculty of Medicine and Pharmacy, University of Besançon, Besançon, France
6 A. H. Roffo Institute of Oncology, University of Buenos Aires, Buenos Aires, Argentina
7 Dermatology Clinic, HillerFormulad Hospital, HillerFormulad, Denmark
8 Dermatology Center, Buxtehude Hospital, Buxtehude, Germany
9 Department of Epidemiology, Murcia Health Council, Murcia, Spain
10 Department of Dermatology, University Federico II of Naples, Naples, Italy
11 Department of Dermatology, Infermi Hospital, Biella, Italy
12 Herault Cancer Registry, Centre Epidaure, Montpellier, France
13 Ragusa Section, Italian League against Cancer, Ragusa, Italy
14 Regional Agency for Public Health of Tuscany, Florence, Italy
15 Institute for Macromolecular Studies, National Research Council, Biella, Italy

Correspondence to Stefano Rosso, Oncology Prevention Center, Piedmont Cancer Registry, Via San Francesco da Paola, 31, Torino 10123, Italy (e-mail: stefano.rosso{at}cpo.it).

Received for publication May 3, 2006. Accepted for publication November 1, 2006.

This study aims to assess type of melanin as a risk indicator for skin tumors, in a sample of melanoma cases and controls within a larger multicenter study (Helios 2), held in Europe and South America in 2001–2002. In each case and control, the melanin content in hair was assessed by three methods: 1) the amount of 2,3,5-pyrroletricarboxylic acid (PTCA); 2) the absorbance ratio with ultraviolet spectroscopy; and 3) the spectra of near-infrared spectroscopy. Statistical analysis was performed in a Bayesian setting, defining priors for confounders and effect modifiers from the larger study data set. Subjects with values of PTCA of less than 85 ng/mg carried an increased risk (26 vs. seven discordant pairs: odds ratio = 4.4, 95% confidence interval: 1.52, 14.54), adjusted by hair color, eye color, and number of nevi (n = ≥40). The absorbance ratio showed a weaker and nonsignificant odds ratio of 1.5. After correction by misclassification, near-infrared spectroscopy was associated with an odds ratio of 2.3 (95% confidence interval: 1.36, 4.22). The amount of PTCA is thus a strong and independent risk indicator for melanoma. Incorporating PTCA determination into epidemiologic studies is therefore recommended.

melanins; melanoma; skin neoplasms; spectroscopy, near-infrared

Abbreviations: HPLC, high-performance liquid chromatography; NIR, near-infrared; PTCA, 2,3,5-pyrroletricarboxylic acid


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.